{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:46Z","timestamp":1781650666181,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7244432"],"award-info":[{"award-number":["7244432"]}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W014090205"],"award-info":[{"award-number":["BRWEP2024W014090205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome is a progressive disease that can affect multiple vital organs. The specific factors contributing to the deterioration of kidney function in stage 4 CKM patients remain unclear, and no relevant clinical prediction model has been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on eleven years of inpatient data. Stage 4 CKM Patients who fulfilled the diagnostic criteria and did not meet the exclusion criteria were enrolled. The outcome was kidney function progression, defined as a sustained decline in estimated glomerular filtration rate of \u2265\u200940% from baseline or initiation of kidney replacement therapy. Based on clinical indicators, predictive models were constructed using Cox regression, LASSO-Cox regression and random survival forest algorithms. Calibration curves, receiver operating characteristic curves, and decision curve analysis were employed to validate the models. The SHapley Additive exPlanations method was used to interpret the final model. Based on the model, a web-based risk calculator was constructed for clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 23,014 subjects with stage 4 CKM were included and randomly divided into two cohorts at a ratio of 2:1 to the development cohort and the validation cohort. During follow-up, 1,772 outcomes (11.6%) occurred in the training cohort and 942 (12.3%) in the validation cohort. Key predictors of kidney function deterioration in stage 4 CKM patients included N-terminal pro-B-type natriuretic peptide, serum albumin, left ventricular ejection fraction, hemoglobin, age, blood urea nitrogen, and urinary protein level. Among the three models, the random survival forest model demonstrated the best discrimination and calibration in the validation set (area under the curve\u2009=\u20090.930, 95% confidence interval: 0.925\u20130.934 in 12 months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The random survival forest model was highly accurate in identifying the special patients with an elevated risk of kidney function deterioration in stage 4 CKM syndrome patients. Our model can be utilized for prospective monitoring and support personalized management strategies for this high-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05001-0","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:35:32Z","timestamp":1776670532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable predictive model for deterioration of kidney function in patients with stage 4 cardiovascular-kidney-metabolic syndrome"],"prefix":"10.1186","volume":"27","author":[{"given":"Fangyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"20","key":"5001_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"20","key":"5001_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"1","key":"5001_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195.","journal-title":"Cardiovasc Diabetol"},{"key":"5001_CR4","doi-asserted-by":"crossref","unstructured":"Xie Z, Yu C, Cui Q, Zhao X, Zhuang J, Chen S, Guan H, Li J. Global burden of the key components of cardiovascular-kidney-metabolic syndrome. J Am Soc Nephrol. 2025.","DOI":"10.1681\/ASN.0000000658"},{"issue":"21","key":"5001_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"6","key":"5001_CR6","doi-asserted-by":"publisher","first-page":"e1004629","DOI":"10.1371\/journal.pmed.1004629","volume":"22","author":"MK Tsai","year":"2025","unstructured":"Tsai MK, Kao JT, Wong CS, Liao CT, Lo WC, Chien KL, Wen CP, Wu MS, Wu MY. Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study. PLoS Med. 2025;22(6):e1004629.","journal-title":"PLoS Med"},{"key":"5001_CR7","doi-asserted-by":"publisher","first-page":"155931","DOI":"10.1016\/j.metabol.2024.155931","volume":"159","author":"Y Handelsman","year":"2024","unstructured":"Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Cherney DZI, et al. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Metab Clin Exp. 2024;159:155931.","journal-title":"Metab Clin Exp"},{"issue":"3","key":"5001_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1681\/ASN.0000000000000050","volume":"34","author":"ME Grams","year":"2023","unstructured":"Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, et al. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts. J Am Soc Nephrology: JASN. 2023;34(3):482\u201394.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"5001_CR9","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.kint.2025.01.041","volume":"107","author":"X Xu","year":"2025","unstructured":"Xu X, Shao X, Hou FF. Risk stratification of metabolic disorder-associated kidney disease. Kidney Int. 2025;107(6):1002\u201310.","journal-title":"Kidney Int"},{"key":"5001_CR10","doi-asserted-by":"crossref","unstructured":"Chauhan K, Nadkarni GN, Fleming F, McCullough J, He CJ, Quackenbush J, Murphy B, Donovan MJ, Coca SG, Bonventre JV. Initial validation of a machine learning-derived prognostic test (KidneyIntelX) integrating biomarkers and electronic health record data to predict longitudinal kidney outcomes. Kidney360. 2020;1(8):731\u2013739.","DOI":"10.34067\/KID.0002252020"},{"issue":"9","key":"5001_CR11","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2337\/dc22-0698","volume":"45","author":"ME Grams","year":"2022","unstructured":"Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, et al. Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes. Diabetes Care. 2022;45(9):2055\u201363.","journal-title":"Diabetes Care"},{"issue":"1","key":"5001_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00701-024-05892-8","volume":"166","author":"O Ciobanu-Caraus","year":"2024","unstructured":"Ciobanu-Caraus O, Aicher A, Kernbach JM, Regli L, Serra C, Staartjes VE. A critical moment in machine learning in medicine: on reproducible and interpretable learning. Acta Neurochir. 2024;166(1):14.","journal-title":"Acta Neurochir"},{"issue":"19","key":"5001_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"6","key":"5001_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","volume":"64","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J kidney diseases: official J Natl Kidney Foundation. 2014;64(6):821\u201335.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"1","key":"5001_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.kint.2020.07.035","volume":"99","author":"K Blazek","year":"2021","unstructured":"Blazek K, van Zwieten A, Saglimbene V, Teixeira-Pinto A. A practical guide to multiple imputation of missing data in nephrology. Kidney Int. 2021;99(1):68\u201374.","journal-title":"Kidney Int"},{"issue":"2","key":"5001_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016;315(2):164\u201374.","journal-title":"JAMA"},{"issue":"7","key":"5001_CR17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00125-021-05444-0","volume":"64","author":"L Chan","year":"2021","unstructured":"Chan L, Nadkarni GN, Fleming F, McCullough JR, Connolly P, Mosoyan G, El Salem F, Kattan MW, Vassalotti JA, Murphy B, et al. Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia. 2021;64(7):1504\u201315.","journal-title":"Diabetologia"},{"key":"5001_CR18","doi-asserted-by":"crossref","unstructured":"Hui M, Ma J, Yang H, Gao B, Wang F, Wang J, Lv J, Zhang L, Yang L, Zhao M. ESKD risk prediction model in a multicenter chronic kidney disease cohort in China: a derivation, validation, and comparison study. J Clin Med. 2023;12(4).","DOI":"10.3390\/jcm12041504"},{"issue":"7","key":"5001_CR19","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.7150\/ijms.95321","volume":"21","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Q, Zou Z, Huang B, Zhong N, Li C, Wang A, Chen Y, Tu S, Wan J. A Dynamic Prediction Model for Renal Progression in Primary Membranous Nephropathy. Int J Med Sci. 2024;21(7):1292\u2013301.","journal-title":"Int J Med Sci"},{"issue":"12","key":"5001_CR20","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.2215\/CJN.04660511","volume":"6","author":"SC Chen","year":"2011","unstructured":"Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrology: CJASN. 2011;6(12):2750\u20138.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"5001_CR21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.2147\/IJGM.S459009","volume":"17","author":"F Li","year":"2024","unstructured":"Li F, Yan F, Liu S, Baheti R, Feng Y, Wan J. The Relationship Between Changes of Left Heart Structure and Function and the Risk of Future Renal Damage in Patients with Essential Hypertension. Int J Gen Med. 2024;17:2475\u201387.","journal-title":"Int J Gen Med"},{"issue":"5","key":"5001_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.ajkd.2023.09.018","volume":"83","author":"SB Ascher","year":"2024","unstructured":"Ascher SB, Berry JD, Katz R, de Lemos JA, Bansal N, Garimella PS, Hallan SI, Wettersten N, Jotwani VK, Killeen AA, et al. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT. Am J kidney diseases: official J Natl Kidney Foundation. 2024;83(5):615\u2013e623611.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"2","key":"5001_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2215\/CJN.04910514","volume":"10","author":"N Bansal","year":"2015","unstructured":"Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clin J Am Soc Nephrology: CJASN. 2015;10(2):205\u201314.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"9","key":"5001_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","volume":"9","author":"K Damman","year":"2007","unstructured":"Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9(9):872\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"5001_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WHW. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"5001_CR26","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840\u201378.","journal-title":"Circulation"},{"issue":"6","key":"5001_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1053\/j.ajkd.2014.08.017","volume":"64","author":"LA Inker","year":"2014","unstructured":"Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J, Greene T, Levey AS. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. Am J kidney diseases: official J Natl Kidney Foundation. 2014;64(6):848\u201359.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"1","key":"5001_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","volume":"75","author":"AS Levey","year":"2020","unstructured":"Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, Greene T, Tighiouart H, Matsushita K, Ballew SH, et al. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. Am J kidney diseases: official J Natl Kidney Foundation. 2020;75(1):84\u2013104.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"9","key":"5001_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/ndt\/gfv269","volume":"31","author":"SV Badve","year":"2016","unstructured":"Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association. 2016;31(9):1425\u201336.","journal-title":"Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"8 Suppl","key":"5001_CR30","first-page":"S160","volume":"27","author":"EO Caplan","year":"2021","unstructured":"Caplan EO, Sheer R, Schmedt N, Evers T, Cockrell M, Tindal M, Pasquale MK, Kovesdy CP. Glomerular filtration rate change and outcomes in type 2 diabetes. Am J Manag Care. 2021;27(8 Suppl):S160\u20137.","journal-title":"Am J Manag Care"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05001-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:24:13Z","timestamp":1781648653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5001"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05001-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in line with the Declaration of Helsinki and received full approval from the Ethics Committee of Peking University Third Hospital (IRB00006761-M2024424). Owing to the retrospective nature of the study, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}